Torcetrapib

Torcetrapib is a high-purity CETP Inhibitor supplied by Mediocon Inc as an Active Pharmaceutical Ingredient (API) conforming to IP / BP / EP / USP specifications. Manufactured at our GMP-certified facility in Aurangabad, Maharashtra, India, it meets the stringent quality requirements of global pharmaceutical manufacturers.

Torcetrapib is a cholesteryl ester transfer protein (CETP) inhibitor developed for increasing HDL cholesterol levels. It is used in cardiovascular research and pharmaceutical studies related to dyslipidemia.

Key Features

• High-purity pharmaceutical grade API
• IP / BP / EP / USP compliant
• Full CoA and MSDS documentation
• GMP certified manufacturing facility

Applications

• Cardiovascular research API
• HDL-raising dyslipidemia studies
• CETP inhibition research
• Lipid-modifying pharmaceutical formulations

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings